⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
globenewswire.com
GSK
Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire.com
GSK
PCRX
OCUL
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
JNJ
GSK
ABBV
REGN
VRTX
GILD
SNY
Transfection Reagent and Equipment: Global Market Review 2021-2025 and Forecast 2026-2031 | Investment Alert: Biopharma's Demand for Transfection Tools Spurs Market Boom
globenewswire.com
GSK
MRK
CAPS
Transfection Reagent and Equipment: Global Market Review 2021-2025 and Forecast 2026-2031 | Investment Alert: Biopharma's Demand for Transfection Tools Spurs Market Boom
globenewswire.com
GSK
MRK
RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
businesswire.com
RAPT
GSK
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica
globenewswire.com
TMO
AMGN
PFE
BMY
GILD
REGN
AZN
LLY
MRK
GSK
Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas
globenewswire.com
GSK
RGNX
OMER
XENE
NMRA
Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas
globenewswire.com
GSK
RGNX
OMER
XENE
Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology
prnewswire.com
GSK